Search Results
Sep 03, 2026, 22:20 ET Sharing opportunities -- A New Landscape of Asia-Pacific Development
recent years, China has continued to widen market access, advance the development of pilot free trade zones, and further facilitate trade and investment through regional frameworks such as RCEP and the China-ASEAN Free Trade Area 3.0. Platforms such as the China International Import Expo, the China International
More news about: China.org.cn
Sep 03, 2026, 21:30 ET Roborock Redefines Human-Centered Cleaning at IFA 2026: Unveiling a Comprehensive Ecosystem from the Living Room to the Pool
prioritizing user needs, the products advanced intelligence works effortlessly in the background, providing autonomous and time-saving solutions that free up people's schedules to spend more time on what truly matters.This commitment to engineering excellence and thoughtful design
More news about: Roborock
Sep 03, 2026, 19:10 ET REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit
disclosed that the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for "analysis of progression-free survival." On this news, the price of Regeneron stock declined more than 6%, according to the complaint.Then, after-market on May 15, 2026, Regeneron
More news about: Robbins Geller Rudman & Dowd LLP
Sep 03, 2026, 19:00 ET KANEKA UBIQUINOL™ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026
cell in the body[iii]. The endogenous antioxidant Ubiquinol, supports the production of energy in the mitochondria and helps reduce cellular free radical damage[iv]. This growing "mitoceutical" category - nutraceuticals purpose-formulated to support mitochondrial function - is central
More news about: Kaneka Ubiquinol™
Sep 03, 2026, 19:00 ET KANEKA UBIQUINOL™ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026
cell in the body[iii]. The endogenous antioxidant Ubiquinol, supports the production of energy in the mitochondria and helps reduce cellular free radical damage[iv]. This growing "mitoceutical" category - nutraceuticals purpose-formulated to support mitochondrial function - is central
More news about: Kaneka Ubiquinol™
Sep 03, 2026, 17:39 ET Lyntris Completes CDR for KSAT Hyperion Satellite Program
Lyntris' filings with the Securities and Exchange Commission, including its registration statement on Form S-1, as amended, copies of which are available free of charge on the SEC's website at www.sec.gov under Lyntris Inc.The forward-looking statements
More news about: Lyntris
Sep 03, 2026, 17:31 ET Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
https://rosenlegal.com/cases/the-ensign-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.What
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 17:29 ET Rosen Law Firm Encourages Putnam Investment Management, LLC Mutual Fund Investors to Inquire About Securities Class Action Investigation
https://rosenlegal.com/cases/putnam-investment-management-llc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.What
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 17:29 ET UWMC Alert: UWM (UWMC) Faces Securities Class Action After Investors Learn of Massive Over-Hedge Loss
company Two Harbors entered into a merger agreement pursuant to which UWM would acquire Two Harbors for about $1.3 billion in UWM stock. Two Harbors was free to receive proposals superior to UWM's.In connection with the proposed acquisition, UWM entered into significant hedging transactions against
More news about: Hagens Berman Sobol Shapiro LLP
Sep 03, 2026, 17:25 ET Rosen Law Firm Encourages Suja Life, Inc. Investors to Inquire About Securities Class Action Investigation - SUJA
https://rosenlegal.com/cases/suja-life-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.What
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 17:10 ET Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL
https://rosenlegal.com/cases/gildan-activewear-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.What
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 17:06 ET ROSEN, LEADING TRIAL ATTORNEYS, Encourages Taboola.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TBLA
https://rosenlegal.com/cases/taboolacom-ltd/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 17:00 ET Prologis to Announce Third Quarter 2026 Results October 15, 2026
outlook on Thursday, October 15, 2026, at 9:00 a.m. PT/12:00 p.m. ET.To access a live broadcast of the call, please dial +1 (877) 897-2615 (toll-free from the United States and Canada) or +1 (201) 689-8514 (from all other countries). A live webcast can be accessed from the Investor Relations section
More news about: Prologis, Inc.
Sep 03, 2026, 17:00 ET NEW PACIFIC REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS AND YEAR ENDED JUNE 30, 2026
Pacific Metals Corp. Phone: (604) 633-1368 Ext. 2231750 – 1066 Hastings Street, Vancouver, BC V6E 3X1, CanadaU.S. & Canada toll-free: 1 (877) 631-0593E-mail: [email protected]
More news about: New Pacific Metals Corp.
Sep 03, 2026, 16:50 ET CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
https://rosenlegal.com/cases/capricor-therapeutics-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 16:46 ET PROJECT HEALTHY MINDS AND HARVARD BUSINESS SCHOOL RESEARCHERS TO EXPAND THE EVIDENCE BASE AROUND WORKFORCE MENTAL HEALTH
programmatic areas: (1) destigmatizing mental health by mobilizing culture-makers; (2) expanding access to mental health services through the world's first free digital mental health marketplace; and (3) advocating for innovative workplace investments in employee mental health. Project Healthy Minds' programmatic
More news about: Project Healthy Minds
Sep 03, 2026, 16:42 ET Lightning Link™ by Aristocrat™ Expands Online Presence on Platforms Across North America with Release of New Game, Tiki Fire™
land-based version, with features that include Cash-on-Reels, bonus prizes, Hold & Spin jackpot action, free games with big symbols, and an exciting top progressive prize. During the Free Games feature, players have the chance to win a x2 multiplier on wilds."Worldwide, Tiki Fire is a player-favorite
More news about: Aristocrat Technologies, Inc.
Sep 03, 2026, 16:38 ET RXT Deadline: RXT Investors with Losses in Excess of $100K Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit
https://rosenlegal.com/cases/rackspace-technology-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 16:18 ET CJ 4DPLEX and B&B Theatres Strengthen Partnership with New 4DX and SCREENX Experiences at Liberty Township, Ohio
immersion that extends beyond traditional video and sound.About SCREENXSCREENX is the world's most immersive platform, breaking free from the boundaries of a single screen to place audiences at the heart of the story.With visuals flowing seamlessly across the walls, SCREENX
More news about: CJ 4DPLEX
Sep 03, 2026, 16:15 ET Tencent Music Entertainment Group Announces Pricing of US$1,000 Million Notes Offering
other documents that the Company has filed with the SEC for more complete information about the Company and the offering. You may obtain these documents free of charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Company, any underwriter
More news about: Tencent Music Entertainment Group
Sep 03, 2026, 16:05 ET Docusign Announces Second Quarter Fiscal 2027 Financial Results
non-GAAP tax rate to be 21%.Free cash flow: We define free cash flow as net cash provided by operating activities less purchases of property and equipment. Free cash flow margin is calculated as free cash flow as a percentage of revenue. We believe free cash flow is an important liquidity
More news about: Docusign, Inc.
Sep 03, 2026, 16:05 ET Flex to Acquire EPC Power, Adding Leading Power Conversion Capabilities for AI Data Centers and Grid Applications
expected timeframe or at all or subject to conditions that are not anticipated; the possibility that the Spin-Off will not qualify for the expected tax-free treatment for U.S. federal income tax purposes; the risk that the Spin-Off may be more difficult, time-consuming, or costly than expected, including
More news about: Flex
Sep 03, 2026, 16:02 ET Aon to Speak at the KBW Insurance Conference
Media [email protected]free (U.S., Canada and Puerto Rico): +1 833 751 8114International: +1 312 381 3024
More news about: Aon plc
Sep 03, 2026, 15:50 ET BZAI Investors Have Opportunity to Lead Blaize Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
https://rosenlegal.com/cases/blaize-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
More news about: THE ROSEN LAW FIRM, P. A.
Sep 03, 2026, 15:15 ET REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Fraud Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
with Libtayo as a first-line treatment for metastatic or locally advanced melanoma (the "Study").The Study's primary endpoint was progression-free survival ("PFS") and Regeneron has characterized the combination as a "potential blockbuster." "Events" – disease progression or death – determined
More news about: Hagens Berman Sobol Shapiro LLP